Q99638 (RAD9A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 91.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cell cycle checkpoint control protein RAD9A Short name=hRAD9 EC=3.1.11.2 Alternative name(s): DNA repair exonuclease rad9 homolog A | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 391 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair. The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex. Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates. The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase. RAD9A possesses 3'->5' double stranded DNA exonuclease activity. Its phosphorylation by PRKCD may be required for the formation of the 9-1-1 complex. Ref.10 Ref.29 |
| Catalytic activity | Exonucleolytic cleavage in the 3'- to 5'-direction to yield nucleoside 5'-phosphates. |
| Subunit structure | Component of the toroidal 9-1-1 (RAD9-RAD1-HUS1) complex, composed of RAD9A, RAD1 and HUS1. The 9-1-1 complex associates with LIG1, POLB, FEN1, RAD17, HDAC1, RPA1 and RPA2. The 9-1-1 complex associates with the RAD17-RFC complex. RAD9A interacts with BCL2L1, FEN1, PRKCD, RAD9B, HUS1, RAD1, ABL1, RPA1, ATAD5 and RPA2. Interacts with DNAJC7 and RHNO1. Ref.8 Ref.9 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.29 |
| Subcellular location | |
| Post-translational modification | Constitutively phosphorylated on serine and threonine amino acids in absence of DNA damage. Hyperphosphorylated by PRKCD and ABL1 upon DNA damage. Its phosphorylation by PRKCD may be required for the formation of the 9-1-1 complex. Ref.7 Ref.14 Ref.16 |
| Sequence similarities | Belongs to the rad9 family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| HUS1 | O60921 | 5 | EBI-2606224,EBI-1056174 | |
| RAD1 | O60671 | 2 | EBI-2606224,EBI-721835 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 391 | 391 | Cell cycle checkpoint control protein RAD9A | PRO_0000225000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 51 – 91 | 41 | Possesses 3'-5' exonuclease activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 266 – 391 | 126 | Sufficient for interaction with ABL1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 28 | 1 | Phosphotyrosine Ref.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 272 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 277 | 1 | Phosphoserine Ref.7 Ref.24 Ref.25 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 328 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 341 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 375 | 1 | Phosphoserine Ref.7 Ref.23 Ref.25 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 380 | 1 | Phosphoserine Ref.7 Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 387 | 1 | Phosphoserine Ref.7 Ref.23 Ref.24 Ref.25 Ref.26 Ref.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 3 | 1 | C → F. Ref.3 | VAR_025410 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 71 | 1 | L → Q. Corresponds to variant rs2422490 [ dbSNP | Ensembl ]. | VAR_051724 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 100 | 1 | S → A. Ref.3 Corresponds to variant rs2066492 [ dbSNP | Ensembl ]. | VAR_025411 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 239 | 1 | H → R. Ref.3 Corresponds to variant rs17880039 [ dbSNP | Ensembl ]. | VAR_025412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 307 | 1 | M → T. Ref.3 Corresponds to variant rs17882466 [ dbSNP | Ensembl ]. | VAR_025413 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 28 | 1 | Y → F: Abolishes phosphorylation by ABL1. Ref.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 272 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-277; A-328; A-341; A-375; A-380 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 277 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-328; A-341; A-375; A-380 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 328 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-341; A-375; A-380 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 341 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-375; A-380 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 375 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-380 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 380 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-375 and A-387. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 387 | 1 | S → A: Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-375 and A-380. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 12 | 1 | V → A in CAG38746. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 130 | 1 | E → A in AAH14848. Ref.6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 2 – 6 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 8 – 21 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 25 – 32 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 35 – 41 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 47 – 53 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 55 – 57 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 62 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 68 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 76 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 77 – 84 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 87 – 93 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 94 – 100 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 106 – 114 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 115 – 117 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 125 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 138 – 140 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 148 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 149 – 156 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 165 – 170 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 172 – 174 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 176 – 181 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 187 – 189 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 194 – 199 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 201 – 203 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 205 – 208 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 214 – 218 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 219 – 231 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 235 – 240 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 241 – 245 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 247 – 252 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 254 – 262 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 267 – 269 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene." Lieberman H.B., Hopkins K.M., Nass M., Demetrick D., Davey S. Proc. Natl. Acad. Sci. U.S.A. 93:13890-13895(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [3] | NIEHS SNPs program Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS PHE-3; ALA-100; ARG-239 AND THR-307. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Trachea. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [7] | "Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling." Roos-Mattjus P., Hopkins K.M., Oestreich A.J., Vroman B.T., Johnson K.L., Naylor S., Lieberman H.B., Karnitz L.M. J. Biol. Chem. 278:24428-24437(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 270-280; 326-329; 373-383 AND 385-390, IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT SER-272; SER-277; SER-328; SER-341; SER-375; SER-380 AND SER-387, MUTAGENESIS OF SER-272; SER-277; SER-328; SER-341; SER-375; SER-380 AND SER-387. |
| [8] | "The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1." St Onge R.P., Udell C.M., Casselman R., Davey S. Mol. Biol. Cell 10:1985-1995(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUS1 AND RAD1. |
| [9] | "Physical interaction among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression." Hang H., Lieberman H.B. Genomics 65:24-33(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUS1 AND RAD1. |
| [10] | "Human DNA damage checkpoint protein hRAD9 is a 3' to 5' exonuclease." Bessho T., Sancar A. J. Biol. Chem. 275:7451-7454(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN EXONUCLEASE ACTIVITY. |
| [11] | "HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins." Cai R.L., Yan-Neale Y., Cueto M.A., Xu H., Cohen D. J. Biol. Chem. 275:27909-27916(2000) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH HDAC1. |
| [12] | "The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9." Rauen M., Burtelow M.A., Dufault V.M., Karnitz L.M. J. Biol. Chem. 275:29767-29771(2000) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH RAD17. |
| [13] | "The J domain of Tpr2 regulates its interaction with the proapoptotic and cell-cycle checkpoint protein, Rad9." Xiang S.L., Kumano T., Iwasaki S.I., Sun X., Yoshioka K., Yamamoto K.C. Biochem. Biophys. Res. Commun. 287:932-940(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DNAJC7. |
| [14] | "c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage." Yoshida K., Komatsu K., Wang H.-G., Kufe D. Mol. Cell. Biol. 22:3292-3300(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ABL1 AND BCL2L1, PHOSPHORYLATION, PHOSPHORYLATION AT TYR-28, MUTAGENESIS OF TYR-28. |
| [15] | "Expression of mammalian paralogues of HRAD9 and Mrad9 checkpoint control genes in normal and cancerous testicular tissue." Hopkins K.M., Wang X., Berlin A., Hang H., Thaker H.M., Lieberman H.B. Cancer Res. 63:5291-5298(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAD9B. |
| [16] | "Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9." Yoshida K., Wang H.-G., Miki Y., Kufe D. EMBO J. 22:1431-1441(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PRKCD, PHOSPHORYLATION, SUBCELLULAR LOCATION. |
| [17] | "Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro." Bermudez V.P., Lindsey-Boltz L.A., Cesare A.J., Maniwa Y., Griffith J.D., Hurwitz J., Sancar A. Proc. Natl. Acad. Sci. U.S.A. 100:1633-1638(2003) [PubMed] [Europe PMC] [Abstract] Cited for: ASSOCIATION OF THE 9-1-1 COMPLEX WITH THE RAD17-RFC COMPLEX, ELECTRON MICROSCOPY OF THE 9-1-1 AND RAD17-RFC COMPLEXES BOUND TO DNA. |
| [18] | "The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair." Toueille M., El-Andaloussi N., Frouin I., Freire R., Funk D., Shevelev I., Friedrich-Heineken E., Villani G., Hottiger M.O., Huebscher U. Nucleic Acids Res. 32:3316-3324(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH POLB. |
| [19] | "The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1." Wang W., Brandt P., Rossi M.L., Lindsey-Boltz L., Podust V., Fanning E., Sancar A., Bambara R.A. Proc. Natl. Acad. Sci. U.S.A. 101:16762-16767(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH FEN1. |
| [20] | "The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery." Smirnova E., Toueille M., Markkanen E., Huebscher U. Biochem. J. 389:13-17(2005) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH LIG1. |
| [21] | "The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity." Friedrich-Heineken E., Toueille M., Taennler B., Buerki C., Ferrari E., Hottiger M.O., Huebscher U. J. Mol. Biol. 353:980-989(2005) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH FEN1, INTERACTION WITH FEN1. |
| [22] | "Interaction and colocalization of Rad9/Rad1/Hus1 checkpoint complex with replication protein A in human cells." Wu X., Shell S.M., Zou Y. Oncogene 24:4728-4735(2005) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH RPA1 AND RPA2, INTERACTION WITH RPA1 AND RPA2. |
| [23] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; SER-380 AND SER-387, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [24] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND SER-387, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277; SER-375 AND SER-387, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [26] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277; SER-375 AND SER-387, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [27] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [28] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387, MASS SPECTROMETRY. |
| [29] | "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling." Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E., Harper J.W., Elledge S.J. Science 332:1313-1317(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH RHNO1, IDENTIFICATION BY MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U53174 mRNA. Translation: AAB39928.1. CR536508 mRNA. Translation: CAG38746.1. AY766122 Genomic DNA. Translation: AAU89725.1. AK315348 mRNA. Translation: BAG37745.1. CH471076 Genomic DNA. Translation: EAW74605.1. BC014848 mRNA. Translation: AAH14848.1. | ||||||||||||||||||||||||
| IPI | IPI00005277. | ||||||||||||||||||||||||
| RefSeq | NP_001230153.1. NM_001243224.1. NP_004575.1. NM_004584.2. | ||||||||||||||||||||||||
| UniGene | Hs.655354. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q99638. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-24255N. DIP-40930N. | ||||||||||||||||||||||||
| IntAct | Q99638. 2 interactions. | ||||||||||||||||||||||||
| MINT | MINT-134869. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000311360. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q99638. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 74717382. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | Q99638. | ||||||||||||||||||||||||
| PeptideAtlas | Q99638. | ||||||||||||||||||||||||
| PRIDE | Q99638. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000307980; ENSP00000311360; ENSG00000172613. | ||||||||||||||||||||||||
| GeneID | 5883. | ||||||||||||||||||||||||
| KEGG | hsa:5883. | ||||||||||||||||||||||||
| UCSC | uc001okr.3. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 5883. | ||||||||||||||||||||||||
| GeneCards | GC11P067159. | ||||||||||||||||||||||||
| HGNC | HGNC:9827. RAD9A. | ||||||||||||||||||||||||
| HPA | HPA006725. | ||||||||||||||||||||||||
| MIM | 603761. gene. | ||||||||||||||||||||||||
| neXtProt | NX_Q99638. | ||||||||||||||||||||||||
| PharmGKB | PA294. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG236850. | ||||||||||||||||||||||||
| HOGENOM | HOG000059650. | ||||||||||||||||||||||||
| HOVERGEN | HBG058989. | ||||||||||||||||||||||||
| InParanoid | Q99638. | ||||||||||||||||||||||||
| KO | K10994. | ||||||||||||||||||||||||
| OMA | GVAITFC. | ||||||||||||||||||||||||
| OrthoDB | EOG4QNMWT. | ||||||||||||||||||||||||
| PhylomeDB | Q99638. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | telomerasepathway. Regulation of Telomerase. | ||||||||||||||||||||||||
| Reactome | REACT_115566. Cell Cycle. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q99638. | ||||||||||||||||||||||||
| Bgee | Q99638. | ||||||||||||||||||||||||
| CleanEx | HS_RAD9A. | ||||||||||||||||||||||||
| Genevestigator | Q99638. | ||||||||||||||||||||||||
| GermOnline | ENSG00000172613. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR026584. Rad9. IPR007268. Rad9/Ddc1. [Graphical view] | ||||||||||||||||||||||||
| PANTHER | PTHR15237. PTHR15237. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF04139. Rad9. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PIRSF | PIRSF009303. Cell_cycle_RAD9. 1 hit. | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | RAD9A. human. | ||||||||||||||||||||||||
| EvolutionaryTrace | Q99638. | ||||||||||||||||||||||||
| GenomeRNAi | 5883. | ||||||||||||||||||||||||
| NextBio | 22862. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | RAD9A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q99638 Secondary accession number(s): B2RCZ8, Q6FI29, Q96C41 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
